METNET: A phase II trial of metformin in patients with well differentiated neuro...
Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours ( Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
31 Mar 2022
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
Role of radiologist in diagnosis and treatment of NET (neuroendocrine tumour)
Prof Thierry De Baere - Institut Gustave Roussy, Paris, France
Role of radiologist in diagnosis and treatment of NET (neuroendocrine tumour) ( Prof Thierry De Baere - Institut Gustave Roussy, Paris, France )
8 May 2019
Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine ...
Prof Sandip Patel - UC San Diego, San Diego, USA
Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine carcinoma ( Prof Sandip Patel - UC San Diego, San Diego, USA )
15 Apr 2019
Umbralisib shows early promise for patients with marginal zone lymphoma
Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA
Umbralisib shows early promise for patients with marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )
11 Apr 2019
Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative diso...
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative disorder in the central nervous system ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
13 Dec 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018
Editor's Choice for February 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
26 Feb 2018
Editor's Choice for September 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for September 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
27 Sep 2017
Problems with survivorship care in Europe
Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy
Problems with survivorship care in Europe ( Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy )
9 Sep 2017
Underprovision and inequality of specialised cancer care
Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Gree...
Underprovision and inequality of specialised cancer care ( Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece )
9 Sep 2017